Marsh A - Search Results

1

Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease.

Agrawal AK, Robertson S, Litwin L, Tringale E, Treadwell M, Hoppe C, Marsh A. Agrawal AK, et al. Among authors: marsh a. Pediatr Blood Cancer. 2019 Feb;66(2):e27525. doi: 10.1002/pbc.27525. Epub 2018 Oct 26. Pediatr Blood Cancer. 2019. PMID: 30362236 Clinical Trial.

2

Renal medullary carcinoma in an adolescent with sickle cell anemia.

Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. Marsh A, et al. Pediatr Blood Cancer. 2014 Mar;61(3):567. doi: 10.1002/pbc.24795. Epub 2013 Sep 24. Pediatr Blood Cancer. 2014. PMID: 24108577 No abstract available.

3

Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease.

Marsh A, Schiffelers R, Kuypers F, Larkin S, Gildengorin G, van Solinge W, Hoppe C. Marsh A, et al. Br J Haematol. 2015 Jan;168(1):135-8. doi: 10.1111/bjh.13110. Epub 2014 Sep 6. Br J Haematol. 2015. PMID: 25196812 Free PMC article.

4

Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.

Lal A, Patterson L, Goldrich A, Marsh A. Lal A, et al. Among authors: marsh a. Pediatr Blood Cancer. 2015 May;62(5):912-4. doi: 10.1002/pbc.25447. Epub 2015 Feb 14. Pediatr Blood Cancer. 2015. PMID: 25683629 Free PMC article.

5

A Quality Improvement Initiative to Improve Emergency Department Care for Pediatric Patients with Sickle Cell Disease.

Treadwell MJ, Bell M, Leibovich SA, Barreda F, Marsh A, Gildengorin G, Morris CR. Treadwell MJ, et al. Among authors: marsh a. J Clin Outcomes Manag. 2014 Feb;21(2):62-70. J Clin Outcomes Manag. 2014. PMID: 26412961 Free PMC article.

6

Erythrocytapheresis for chronic transfusion therapy in sickle cell disease: survey of current practices and review of the literature.

Kelly S, Quirolo K, Marsh A, Neumayr L, Garcia A, Custer B. Kelly S, et al. Among authors: marsh a. Transfusion. 2016 Nov;56(11):2877-2888. doi: 10.1111/trf.13800. Epub 2016 Oct 19. Transfusion. 2016. PMID: 27759170 Review.

7

Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management.

Fearon A, Marsh A, Kim J, Treadwell M. Fearon A, et al. Among authors: marsh a. Pediatr Blood Cancer. 2019 Feb;66(2):e27535. doi: 10.1002/pbc.27535. Epub 2018 Nov 1. Pediatr Blood Cancer. 2019. PMID: 30387290 Free PMC article.

8

Barriers to Pediatric Sickle Cell Disease Guideline Recommendations.

Cabana MD, Kanter J, Marsh AM, Treadwell MJ, Rowland M, Stemmler P, Bardach NS. Cabana MD, et al. Glob Pediatr Health. 2019 May 3;6:2333794X19847026. doi: 10.1177/2333794X19847026. eCollection 2019. Glob Pediatr Health. 2019. PMID: 31106244 Free PMC article.

9

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.

Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.

10

Improving Preventive Care for Children With Sickle Cell Anemia: A Quality Improvement Initiative.

Cabana MD, Marsh A, Treadwell MJ, Stemmler P, Rowland M, Bender MA, Bhasin N, Chung JH, Hassell K, Abdul Rashid NFN, Wong TE, Bardach NS. Cabana MD, et al. Among authors: marsh a. Pediatr Qual Saf. 2020 Dec 28;6(1):e379. doi: 10.1097/pq9.0000000000000379. eCollection 2021 Jan-Feb. Pediatr Qual Saf. 2020. PMID: 33409431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

814 results

Search Page